| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/09/2013 | CN102861047A Application of Gypensapogenin A in medicine for preventing respiratory syncytial virus |
| 01/09/2013 | CN102861039A Medicinal formulation for treating beriberi |
| 01/09/2013 | CN102861031A Application of Gypensapogenin B in medicine for resisting respiratory syncytial virus |
| 01/09/2013 | CN102861029A Application of Gypensapogenin B in medicine for treating hemorrhagic fever with renal syndrome |
| 01/09/2013 | CN102861027A Application of Gypensapogenin A in medicine for preventing human fungi |
| 01/09/2013 | CN102861026A Application of Gypensapogenin A in medicine for treating influenza virus A |
| 01/09/2013 | CN102861025A Application of Gypensapogenin B in medicine for treating Dengue virus infection |
| 01/09/2013 | CN102861016A Application of jatrorrhizine for treating candida albicans infectious diseases |
| 01/09/2013 | CN102861015A Stable amoxicillin and clavulanate potassium sustained release preparation and preparation technology |
| 01/09/2013 | CN102860999A 1-deoxidation-D-xylulose5-phosphoric acid reduction isomerization enzyme inhibitor and preparation method thereof |
| 01/09/2013 | CN102860995A Enrofloxacin effervescent granule for livestock and preparation method thereof |
| 01/09/2013 | CN102860992A Tiacumicins B sustained release or controlled release composition orally taken for one time per day |
| 01/09/2013 | CN102860990A Cefetamet pivoxil hydrochloride dispersible tablet and preparation method thereof |
| 01/09/2013 | CN102860985A Tebipenem pivoxil oral preparation and preparation method thereof |
| 01/09/2013 | CN102860984A Method for preparing compound sulfachloropyridazine sodium powder |
| 01/09/2013 | CN102860971A Compound toothpaste with functions of antisepsis, anti-inflammation, acid prevention and desensitization, and preparation method thereof |
| 01/09/2013 | CN102860932A Gingivitis and gingivitis ozostomia preventing mouthwash prepared by anti-porphyromonas gingivalis and IgY antibody with fusobacterium nucleatum specificity |
| 01/09/2013 | CN102860923A Nano-silver antibacterial liquid soap and preparation method thereof |
| 01/09/2013 | CN102860778A Food sterilization wet wipe suitable for hand-mouth contact |
| 01/09/2013 | CN102860518A Smashing-free fruit active ingredient extracting method |
| 01/09/2013 | CN102512359B Mangiferin cream with anti-herpes virus effect |
| 01/09/2013 | CN102329746B Porcine streptococcus disease and haemophilus parasuis disease combined inactivated vaccine and preparation method thereof |
| 01/09/2013 | CN102302774B Peste des petits ruminants recombinant goat pox virus live vector vaccines |
| 01/09/2013 | CN102302458B Long-acting sustained-release wound dressing containing levofloxacin sustained-release microspheres, and preparation method thereof |
| 01/09/2013 | CN102258497B Lamivudine tablet composition and preparation method thereof |
| 01/09/2013 | CN102226203B Construction and application of dual shRNA expression plasmid of dual chU6 promoter |
| 01/09/2013 | CN102226157B Lactobacillus fermentum and application thereof |
| 01/09/2013 | CN102205126B Application of combined catechin matters together with antibacterial agents |
| 01/09/2013 | CN102199611B Clostridium difficile exotoxin A carboxy-terminal gene sequence with optimized codon and nucleic acid vaccine thereof |
| 01/09/2013 | CN102188135B Chinese medicine pillow for preventing and treating cold |
| 01/09/2013 | CN102178792B Shiqi exogenous Chinese medicinal buccal tablets |
| 01/09/2013 | CN102178726B Chinese medicinal composition and spraying agent for preventing emerging respiratory infectious diseases |
| 01/09/2013 | CN102138924B Cefcapene pivoxil hydrochloride composition and preparation method thereof |
| 01/09/2013 | CN102133245B Brucea javanica oil obtained by reducing content of protein, and medicine composite and preparation method thereof |
| 01/09/2013 | CN102041263B Chicken alpha interferon/interleukin 2 chimeric gene |
| 01/09/2013 | CN102038722B Composition for preventing infection of new influenza A (H1N1) virus comprising ginkgo extract, air filter comprising the same, and air cleaning device comprising the filter |
| 01/09/2013 | CN102008735B Small molecular DNA vaccine and preparation method thereof |
| 01/09/2013 | CN101978852B Microbial feed additive for treating piglet yellow and white dysentery and preparation method thereof |
| 01/09/2013 | CN101954003B Method for preparing Chinese medicinal granules for treating cold |
| 01/09/2013 | CN101948811B Method for expanding antigen spectrum of foot-and-mouth disease vaccine strain by reverse genetic operation and preparation method of vaccine |
| 01/09/2013 | CN101921319B Rubiaceae-type cyclopeptides, medicinal compositions using same as active ingredients, and preparation method and application thereof |
| 01/09/2013 | CN101824021B Method for extracting catechin small molecules in lotus root and application thereof |
| 01/09/2013 | CN101816722B Wash-free antipruritic antibacterial gel with Chinese medicament components and preparation method thereof |
| 01/09/2013 | CN101798298B Imidazole derivatives |
| 01/09/2013 | CN101711243B 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives |
| 01/09/2013 | CN101636411B Interferon alpha 2a modified by polyethylene glycol, synthesis process and application thereof |
| 01/09/2013 | CN101434611B Nitrogen heterocyclic ring substituted antibiotic, and preparation method and use thereof |
| 01/09/2013 | CN101381386B Lactose-azithromycin hydrate, preparation and use thereof |
| 01/09/2013 | CN101268095B Bifunctional protein anchors |
| 01/09/2013 | CN101185692B Nauclea officinalis extract and preparation and use thereof |
| 01/09/2013 | CN101124318B Novel strain conferring anti-disease properties to host and bacterial cell composition |
| 01/09/2013 | CN101068540B Antiviral and immunostimulating marine fish oil composition |
| 01/08/2013 | US8349869 Macrocylic inhibitors of hepatitis C virus |
| 01/08/2013 | US8349836 Phthalazine derivatives as inhibitors of protein kinase |
| 01/08/2013 | US8349805 Use of Gonadorelin as a therapeutic agent |
| 01/08/2013 | US8349606 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 01/08/2013 | CA2696826C Process for preparing inhibitors of nucleoside metabolism |
| 01/08/2013 | CA2653941C Substituted amino purine derivatives and uses thereof |
| 01/08/2013 | CA2569514C Oral preparations and process for production thereof |
| 01/08/2013 | CA2561876C Antimicrobial compositions and methods for their use |
| 01/08/2013 | CA2558771C Multiple promoter expression cassettes for simultaneous delivery of rnai agents |
| 01/08/2013 | CA2543318C Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto |
| 01/08/2013 | CA2514667C Adjuvanted influenza vaccine |
| 01/08/2013 | CA2510337C Topoisomerase-targeting agents |
| 01/08/2013 | CA2490121C Modified phospholipids |
| 01/08/2013 | CA2489004C Agonistic binding molecules to the human ox40 receptor |
| 01/08/2013 | CA2485882C A therapeutic agent for mycobacterium tuberculosis comprising 15k granulysin as the active ingredient |
| 01/08/2013 | CA2478731C Carbamates as hiv protease inhibitors |
| 01/08/2013 | CA2478065C Macrocyclic compounds useful as pharmaceuticals |
| 01/08/2013 | CA2470262C Glycoconjugates and their use as potential vaccines against infection by shigella flexneri |
| 01/08/2013 | CA2468539C Delivery of medicaments to the nail |
| 01/08/2013 | CA2457441C Infectious and attenuated bovine viral diarrhea virus clone; methods for their production and use |
| 01/08/2013 | CA2454361C Humanized antibodies |
| 01/08/2013 | CA2409873C Hcv variants |
| 01/08/2013 | CA2390095C Method and system to remove cytokine inhibitor in patients |
| 01/08/2013 | CA2341352C Oral vaccine compositions |
| 01/08/2013 | CA2285394C Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases |
| 01/08/2013 | CA2223608C Vaccine for porcine reproductive and respiratory syndrome virus |
| 01/08/2013 | CA2221511C Vaccine comprising a polysaccharide antigen-carrier protein conjugate and free carrier protein |
| 01/08/2013 | CA2216139C Recombinant infectious laryngotracheitis virus and uses thereof |
| 01/04/2013 | CA2745987A1 Sorbent pellets including oxygen carriers |
| 01/03/2013 | WO2013003641A2 Serpin fusion polypeptides and methods of use thereof |
| 01/03/2013 | WO2013003383A1 Bridged bicyclic compounds for the treatment of bacterial infections |
| 01/03/2013 | WO2013002449A1 Epitope and its use of hepatitis b virus surface antigen |
| 01/03/2013 | WO2013002439A1 Antifungal composition comprising cis-cyclo(l-phe-l-pro) having genus ganoderma fungus-specific antifungal activity |
| 01/03/2013 | WO2013002421A1 Antimicrobial composition |
| 01/03/2013 | WO2013002357A1 Hiv replication inhibitor |
| 01/03/2013 | WO2013002215A1 Cephem compound having pyridinium group |
| 01/03/2013 | WO2013001890A1 Soyasapogenol composition |
| 01/03/2013 | WO2013001830A1 Nucleoside antibiotic derivative |
| 01/03/2013 | WO2013001819A1 SOLUBLE INTEGRIN α4 MUTANT |
| 01/03/2013 | WO2013001372A2 Methods and compositions for inhibition of activation of regulatory t cells |
| 01/03/2013 | WO2013001310A1 Macrocyclic compounds and their use as cdk8 inhibitors |
| 01/03/2013 | WO2013001167A1 Non-toxic compositions for decreasing the risk of cancer caused by oral microbes |
| 01/03/2013 | WO2013000856A1 Hcv combination therapy |
| 01/03/2013 | WO2013000855A1 Hcv combination therapy |
| 01/03/2013 | WO2013000543A1 Benzopyranobenzothiazinones and their use as fungicides, antibiotics and antitumor agents |
| 01/03/2013 | WO2013000280A1 9-sulfonyl-9h-purine derivative, preparation method and use thereof |
| 01/03/2013 | WO2013000234A1 A novel recomnimant bifunctional fusion protein and its preparation and use |
| 01/03/2013 | WO2013000093A1 Location-specific bacterial management |